APTIMA PCA3 Molecular Urine Test: Development of a Method to Aid in the Diagnosis of Prostate Cancer
Top Cited Papers
Open Access
- 1 June 2006
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 52 (6) , 1089-1095
- https://doi.org/10.1373/clinchem.2005.063289
Abstract
Background: Prostate cancer gene 3 (PCA3) encodes a prostate-specific mRNA that has shown promise as a prostate cancer diagnostic tool. This report describes the characterization of a prototype quantitative PCA3-based test for whole urine.Keywords
This publication has 16 references indexed in Scilit:
- Innovations in Serum and Urine Markers in Prostate CancerEuropean Urology, 2005
- uPM3, a new molecular urine test for the detection of prostate cancerUrology, 2004
- Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per MilliliterNew England Journal of Medicine, 2004
- DD3PCA3-based Molecular Urine Analysis for the Diagnosis of Prostate CancerEuropean Urology, 2003
- Highly Sensitive Multiplex Assay for Detection of Human Immunodeficiency Virus Type 1 and Hepatitis C Virus RNAJournal of Clinical Microbiology, 2002
- Molecular diagnostic testing for infectious diseases using TMA technologyExpert Review of Molecular Diagnostics, 2001
- DNA-based detection of prostate cancer in urine after prostatic massageUrology, 2001
- THE USE OF TELOMERASE ACTIVITY FOR THE DETECTION OF PROSTATIC CANCER CELLS AFTER PROSTATIC MASSAGEJournal of Urology, 2001
- The role of prostate needle biopsy in evaluation of chemopreventive agentsUrology, 2001
- Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissueUrology, 2000